Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$4.00 USD
-0.30 (-6.98%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $4.00 0.00 (0.00%) 7:56 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.90 | 0.00% |
Earnings Summary
For their last quarter, Relmada Therapeutics (RLMD) reported earnings of -$0.84 per share, beating the Zacks Consensus Estimate of $-0.88 per share. This reflects a positive earnings surprise of 4.55%. Look out for RLMD's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.90 per share, reflecting a year-over-year decrease of 3.45%.
Earnings History
Price & Consensus
Zacks News for RLMD
Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More
RLMD: What are Zacks experts saying now?
Zacks Private Portfolio Services